Advances in drug delivery related biosensors and medical devices

Evolution of drug-eluting biomedical implants for sustained drug delivery

In the field of drug delivery, the most commonly used treatments have traditionally been systemically delivered using oral or intravenous administration. The problems associated with this type of delivery is that the drug concentration is controlled by first pass metabolism, and therefore may not always remain within the therapeutic window. Implantable drug delivery systems (IDDSs) are an excellent alternative to traditional delivery because they offer the ability to precisely control the drug release, deliver drugs locally to the target tissue, and avoid the toxic side effects often experienced with systemic administration. Since the creation of the first FDA-approved IDDS in 1990, there has been a surge in research devoted to fabricating and testing novel IDDS formulations. The versatility of these systems is evident when looking at the various biomedical applications that utilize IDDSs. This review provides an overview of the history of IDDSs, with examples of the different types of IDDS formulations, as well as looking at current and future biomedical applications for such systems. Though there are still obstacles that need to be overcome, ever-emerging new technologies are making the manufacturing of IDDSs a rewarding therapeutic endeavor with potential for further improvements.

A modified nanocomposite biosensor for quantitative l-glutamate detection in beef

A new biosensor for detecting l-glutamate (l-Glu) in beef was developed. Firstly, a bare Au electrode was surface-modified by gold nanoparticles (Au NPs), graphene oxide (GO), and chitosan (CS) as immobilized materials, and then its surface was connected with l-glutamate oxidase (GluOx). The modified Au NPs/GO/CS electrode was characterized by scanning electron microscopy, and the formation mechanism was elaborated. The response current of the l-Glu biosensor maximized to 0.08 mA at pH 7.5 and 0.09 mA at 30 °C, with a detection range of 0.2-1.4 mM and a detection limit of 0.023 mM. The l-Glu biosensor had high accuracy, and its results linearly fitted with those of the amino acid analyzer with a coefficient of 0.996. The l-Glu biosensor had high selectivity, repeatability, and stability and detected higher l-Glu content in the cooked beef than in the raw beef.